Apellis Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of novel therapeutic compounds to treat diseases with high unmet needs. It offers EMPAVELI for the tre...
Q2 2026
Jul 30, 2026
Q1 2026
May 7, 2026
FY 2025
Feb 24, 2026
Q4 2025
Q3 2025
Oct 30, 2025
